08:44 AM EDT, 07/21/2025 (MT Newswires) -- Evotec (EVO) shares were down 13% in recent Monday premarket activity, after the life science company cut its fiscal 2025 revenue guidance.

Bruker ( BRKR ) shares slipped nearly 11% after the company said it expects Q2 adjusted earnings in the range of $0.32 to $0.34, representing roughly a $0.19 decline from a year earlier.

Sarepta Therapeutics ( SRPT ) shares were falling 10% after the company said in a regulatory filing the US Food and Drug Administration has put a clinical hold on its investigational gene therapy clinical studies for limb girdle muscular dystrophy.

Webull ( BULL ) shares slid 8%, erasing Friday's gains.